News | January 14, 2023
Global (68M) cardiomyopathies market set to reach $9.63 bn by 2031: GlobalData
The cardiomyopathies market in the 68M is set to grow at a CAGR of 12.1%
The cardiomyopathies market in the 68M is set to grow at a CAGR of 12.1%
The goal of Dozee’s partnership with BII is to improve access to healthcare across India and alleviate the workload of healthcare workers, reduce nurse burnout and fatigue in hospital wards
OriCiro's synthetic biology and enzyme technologies will support Moderna's expanding portfolio of therapeutics and vaccines
Collaboration to generate and develop therapeutics for oncology and non-oncology conditions
In a time when conversations around mental health have become ever more urgent Vaidya’s work is extremely contextual
Acquisitions have the potential to add at least $1 billion in sales by 2028
Supriya Lifescience Limited has informed that the European Directorate for the Quality of Medicines (EDQM) has granted Attestation of Inspection (EU-GMP) for Lote API Facility, Ratnagiri, Maharashtra.
The unit will have installed manufacturing capacity of over 15 million vials annually that includes lyophilized vials, all in the anti-cancer segment
Over 30 years of deep life sciences industry experience with a wide range of expertise in corporate governance, capital markets, licensing and strategic collaborations
Passengers arriving from 6 high-risk countries are now mandatorily required to upload their negative RT-PCR test
Subscribe To Our Newsletter & Stay Updated
